companydirectorylist.com  글로벌 비즈니스 디렉토리 및 회사 디렉토리
검색 비즈니스 , 회사 , 산업 :


국가 목록
미국 회사 디렉토리
캐나다 기업 목록
호주 비즈니스 디렉토리
프랑스 회사 목록
이탈리아 회사 목록
스페인 기업 디렉토리
스위스 기업 목록
오스트리아 회사 디렉토리
벨기에 비즈니스 디렉토리
홍콩 기업 목록
중국 사업 목록
대만 기업 목록
아랍 에미레이트 회사 디렉토리


산업 카탈로그
미국 산업 디렉토리














  • Rinvoq: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, giant cell arteritis, and polyarticular juvenile idiopathic arthritis
  • RINVOQ® (upadacitinib) for RA, PsA, AD, AS, nr-axSpA, UC, CD . . .
    RINVOQ is a Janus kinase (JAK) inhibitor that works inside your cells to block certain signals that are thought to cause inflammation RINVOQ, a once-daily pill, has been shown to help tame symptoms in 9 conditions Have you or a loved one been prescribed RINVOQ? Share your experience to help inform and inspire people like yourself To participate:
  • Rinvoq (upadacitinib) - Uses, Side Effects, and More
    Overview: Rinvoq is used for certain types of arthritis, arteritis, atopic dermatitis, ulcerative colitis, and Crohn’s disease It calms your immune system by blocking a
  • Rinvoq: Side effects, cost, uses, dosage, and more
    Rinvoq is a brand-name drug that’s prescribed for rheumatoid arthritis and other conditions Rinvoq contains the active ingredient upadacitinib and is a type of disease-modifying antirheumatic
  • RINVOQ® (upadacitinib) - Official Healthcare Professional Site
    Learn about RINVOQ® (upadacitinib), approved for RA, PsA, AS, nr-axSpA, pJIA, GCA, AD, UC, and CD See full Prescribing Information and Important Safety Information, including BOXED WARNING
  • Rinvoq (Upadacitinib): Uses, Side Effects, Tips More - GoodRx
    Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor It's used to treat certain inflammatory conditions, such as rheumatoid arthritis (RA), ulcerative colitis (UC), and eczema (atopic dermatitis)
  • Upadacitinib (Rinvoq) — RheumInfo
    Rinvoq (upadacitinib) is a Disease Modifying Anti-Rheumatic Drug (DMARD) that’s currently used to treat rheumatoid arthritis with and without methotrexate, psoriatic arthritis, and ankylosing spondylitis




비즈니스 디렉토리, 기업 디렉토리
비즈니스 디렉토리, 기업 디렉토리 copyright ©2005-2012 
disclaimer